Cito Capital Group, LLC Bristol Myers Squibb CO Transaction History
Cito Capital Group, LLC
- $272 Million
- Q4 2024
A detailed history of Cito Capital Group, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Cito Capital Group, LLC holds 33,250 shares of BMY stock, worth $1.86 Million. This represents 0.69% of its overall portfolio holdings.
Number of Shares
33,250
Previous 30,250
9.92%
Holding current value
$1.86 Million
Previous $1.57 Million
20.19%
% of portfolio
0.69%
Previous 0.58%
Shares
15 transactions
Others Institutions Holding BMY
# of Institutions
2,751Shares Held
1.57BCall Options Held
28MPut Options Held
28.7M-
Vanguard Group Inc Valley Forge, PA190MShares$10.6 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.86 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$5.36 Billion0.44% of portfolio
-
State Street Corp Boston, MA95.1MShares$5.31 Billion0.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.37 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $119B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...